An Overview of Statistical Considerations for Cardiovascular Biomarker Tests
 View Presentation
*Arkendra De, FDA/CDRH Keywords: measurement validation, clinical evaluation, cardiovascular The aim of this presentation is to provide an overview of considerations that impact the statistical evaluation of cardiovascular biomarker tests. Considerations for measurement validation and clinical evaluation studies will be discussed. This presentation is based on De, A et al (2013) Journal of Cardiovascular Translational Research, Volume 6, Issue 4, pages 449-457.
|
Key Dates
-
November 1 - December 17, 2013
Online proposal submission for a session, short course and Town Hall Open -
January 6 - March 11, 2014
Online proposal submission for Roundtables Open -
April 30 - May 28, 2014
Abstract Submission Open -
June 4, 2014
Online Registration Opens -
August 8 - August 22, 2014
Invited Abstract Editing -
August 11, 2014
Short Course materials due from Instructors -
September 1, 2014
Housing Deadline -
September 15, 2014
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 22 - September 24, 2014
Marriott Wardman Park, Washington, DC
